-
公开(公告)号:US20050171174A1
公开(公告)日:2005-08-04
申请号:US10503602
申请日:2003-02-06
IPC分类号: A61K31/4188 , A61P1/02 , A61P1/04 , A61P3/10 , A61P7/02 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P13/10 , A61P17/00 , A61P17/02 , A61P17/06 , A61P19/02 , A61P19/10 , A61P25/00 , A61P27/02 , A61P29/00 , A61P31/18 , A61P35/00 , A61P37/02 , A61P37/08 , A61P43/00 , C07D487/04
CPC分类号: C07D487/04
摘要: The present invention relates to a compound of formula (I): wherein R is hydrogen atom, hydroxyl group or carbamoyl group, and n is 1 or 2, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,其中R是氢原子,羟基或氨基甲酰基,n是1或2。